The Outlook article ‘Combinations on trial’ (Nature 552, S67–S69; 2017) overstated the number of immunotherapeutic agents in development at more than 2,400. In fact, there are roughly 2,000.
- CORRECTION
Combinations on trial
Nature 553, 155 (2018)
doi: https://doi.org/10.1038/d41586-018-00415-9